The Effect of the Ultra-Marathon Run at a Distance of 100 Kilometers on the Concentration of Selected Adipokines in Adult Men
Abstract
:1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Biochemical Analysis
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Kershaw, E.E.; Flier, J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004, 89, 2548–2556. [Google Scholar] [CrossRef] [PubMed]
- Banerjee, R.R.; Lazar, M.A. Resistin: Molecular history and prognosis. J. Mol. Med. 2003, 81, 218–226. [Google Scholar] [CrossRef] [PubMed]
- Patel, S.D.; Rajala, M.W.; Rossetti, L.; Scherer, P.E.; Shapiro, L. Disulfide-dependent multimeric assembly of resistin family hormones. Science 2004, 304, 1154–1158. [Google Scholar] [CrossRef]
- Goralski, K.B.; McCarthy, T.C.; Hanniman, E.A.; Zabel, B.A.; Butcher, E.C.; Parlee, S.D.; Muruganandan, S.; Sinal, C.J. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 2007, 282, 28175–28188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Roh, S.G.; Song, S.H.; Choi, K.C.; Katoh, K.; Wittamer, V.; Parmentier, M.; Sasaki, S. Chemerin—A new adipokine that modulates adipogenesis via its own receptor. Biochem. Biophys. Res. Commun. 2007, 362, 1013–1018. [Google Scholar] [CrossRef] [Green Version]
- Bozaoglu, K.; Bolton, K.; McMillan, J.; Zimmet, P.; Jowett, J.; Collier, G.; Walder, K.; Segal, D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007, 148, 4687–4694. [Google Scholar] [CrossRef]
- Patel, L.; Buckels, A.C.; Kinghorn, I.J.; Murdock, P.R.; Holbrook, J.D.; Plumpton, C.; Macphee, C.H.; Smith, S.A. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun. 2003, 300, 472–476. [Google Scholar] [CrossRef]
- Filkova, M.; Haluzik, M.; Gay, S.; Senolt, L. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin. Immunol. 2009, 133, 157–170. [Google Scholar] [CrossRef] [Green Version]
- Wang, L.K.; Wang, H.; Wu, X.L.; Shi, L.; Yang, R.M.; Wang, Y.C. Relationships among resistin, adiponectin, and leptin and microvascular complications in patients with type 2 diabetes mellitus. J. Int. Med. Res. 2019, in press. [Google Scholar] [CrossRef]
- Liu, W.; Zhou, X.; Li, Y.; Zhang, S.; Cai, X.; Zhang, R.; Gong, S.; Han, X.; Ji, L. Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study. Medicine (Baltimore) 2020, 99, e19052. [Google Scholar] [CrossRef]
- Steppan, C.M.; Bailey, S.T.; Bhat, S.; Brown, E.J.; Banerjee, R.R.; Wright, C.M.; Patel, H.R.; Ahima, R.S.; Lazar, M.A. The hormone resistin links obesity to diabetes. Nature 2001, 409, 307–312. [Google Scholar] [CrossRef] [PubMed]
- Park, H.K.; Kwak, M.K.; Kim, H.J.; Ahima, R.S. Linking resistin, inflammation, and cardiometabolic diseases. Korean J. Intern. Med. 2017, 32, 239–247. [Google Scholar] [CrossRef] [PubMed]
- Mocan-Hognogi, L.D.; Goidescu, C.M.; Farcaş, A.D. Usefulness of the adipokines as biomarkers of ischemic cardiac dysfunction. Dis. Markers 2018, 2018, 8. [Google Scholar] [CrossRef]
- Jamaluddin, M.S.; Weakley, S.M.; Yao, Q.; Chen, C. Resistin: Functional roles and therapeutic considerations for cardiovascular disease. Br. J. Pharmacol. 2012, 165, 622–632. [Google Scholar] [CrossRef] [Green Version]
- Marcelino-Rodrõguez, I.; Almeida Gonzalez, D.; Aleman-Sanchez, J.J.; Brito Dõaz, B.; Rodrõguez Perez, M.D.C.; Gannar, F.; Dominguez Coello, S.; Cuevas Fernandez, F.J.; Cabrera de Leon, A. Inverse association of resistin with physical activity in the general population. PLoS ONE 2017, 12, e0182493. [Google Scholar] [CrossRef] [Green Version]
- Jamurtas, A.Z.; Theocharis, V.; Koukoulis, G.; Stakias, N.; Fatouros, I.G.; Kouretas, D.; Koutedakis, Y. The effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males. Eur. J. Appl. Physiol. 2006, 97, 122–126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Varady, K.A.; Bhutani, S.; Church, E.C.; Phillips, S.A. Adipokine responses to acute resistance exercise in trained and untrained men. Med. Sci. Sports Exerc. 2010, 42, 456–462. [Google Scholar] [CrossRef] [PubMed]
- Vuolteenaho, K.; Leppanen, T.; Kekkonen, R.; Korpela, R.; Moilanen, E. Running a marathon induces changes in adipokine levels and in markers of cartilage degradation—Novel role for resistin. PLoS ONE 2014, 9, e110481. [Google Scholar] [CrossRef]
- Roupas, N.D.; Mamali, I.; Maragkos, S.; Leonidou, L.; Armeni, A.K.; Markantes, G.K.; Tsekouras, A.; Sakellaropoulos, G.C.; Markou, K.B.; Georgopoulos, N.A. The effect of prolonged aerobic exercise on serum adipokine levels during an ultra-marathon endurance race. Hormones (Athens) 2013, 12, 275–282. [Google Scholar] [CrossRef] [Green Version]
- Cash, J.L.; Hart, R.; Russ, A.; Dixon, J.P.; Colledge, W.H.; Doran, J.; Hendrick, A.G.; Carlton, M.B.; Greaves, D.R. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 2008, 205, 767–775. [Google Scholar] [CrossRef] [Green Version]
- Rourke, J.; Dranse, H.J.; Sinal, C.J. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obes. Rev. 2013, 14, 245–262. [Google Scholar] [CrossRef] [PubMed]
- De Henau, O.; Degroot, G.N.; Imbault, V.; Robert, V.; De Poorter, C.; Mcheik, S.; Galés, C.; Parmentier, M.; Springael, J.Y. Signaling properties of chemerin receptors CMKLR1, GPR1 and CCRL2. PLoS ONE 2016, 11, e0164179. [Google Scholar] [CrossRef] [PubMed]
- Dimitriadis, G.K.; Kaur, J.; Adya, R.; Miras, A.D.; Mattu, H.S.; Hattersley, J.G.; Kaltsas, G.; Tan, B.K.; Randeva, H.S. Chemerin induces endothelial cell inflammation: Activation of nuclear factor-kappa beta and monocyte-endothelial adhesion. Oncotarget 2018, 9, 16678–16690. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ferland, D.J.; Garver, H.; Contreras, G.A.; Fink, G.D.; Watts, S.W. Chemerin contributes to in vivo adipogenesis in a location-specific manner. PLoS ONE 2020, 15, e0229251. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Helfer, G.; Wu, Q.F. Chemerin: A multifaceted adipokine involved in metabolic disorders. J. Endocrinol. 2018, 238, R79–R94. [Google Scholar] [CrossRef]
- Chakaroun, R.; Raschpichler, M.; Klöting, N.; Oberbach, A.; Flehmig, G.; Kern, M.; Schön, M.R.; Shang, E.; Lohmann, T.; Fasshauer, M.; et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 2012, 61, 706–714. [Google Scholar] [CrossRef] [Green Version]
- Faramarzi, M.; Banitalebi, E.; Nori, S.; Farzin, S.; Taghavian, Z. Effects of rhythmic aerobic exercise plus core stability training on serum omentin, chemerin and vaspin levels and insulin resistance of overweight women. J. Sports Med. Phys. Fit. 2016, 56, 476–482. [Google Scholar]
- Sell, H.; Laurencikiene, J.; Taube, A.; Eckardt, K.; Cramer, A.; Horrighs, A.; Arner, P.; Eckel, J. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009, 58, 2731–2740. [Google Scholar] [CrossRef] [Green Version]
- Menzel, J.; di Giuseppe, R.; Biemann, R.; Wittenbecher, C.; Aleksandrova, K.; Eichelmann, F.; Fritsche, A.; Schulze, M.B.; Boeing, H.; Isermann, B.; et al. Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study. Sci. Rep. 2017, 7, 14171. [Google Scholar] [CrossRef] [Green Version]
- Zhou, X.; Tao, Y.; Chen, Y.; Xu, W.; Qian, Z.; Lu, X. Serum chemerin as a novel prognostic indicator in chronic heart failure. J. Am. Heart Assoc. 2019, 8, e012091. [Google Scholar] [CrossRef] [Green Version]
- Leiherer, A.; Muendlein, A.; Kinz, E.; Vonbank, A.; Rein, P.; Fraunberger, P.; Malin, C.; Saely, C.H.; Drexel, H. High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events—Insights from phenotype and genotype characterization. Vascul. Pharmacol. 2016, 77, 60–68. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Spyrou, N.; Avgerinos, K.I.; Mantzoros, C.S.; Dalamaga, M. Classic and novel adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies. Curr. Obes. Rep. 2018, 7, 260–275. [Google Scholar] [CrossRef] [PubMed]
- Treeck, O.; Buechler, C.; Ortmann, O. Chemerin and cancer. Int. J. Mol. Sci. 2019, 20, 3750. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kasapis, C.; Thompson, P.D. The effects of physical activity on serum C-reactive protein and inflammatory markers: A systematic review. J. Am. Coll. Cardiol. 2005, 45, 1563–1569. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schalt, A.; Johannsen, M.M.; Kim, J.; Chen, R.; Murphy, C.J.; Coker, M.S.; Gunga, H.-C.; Coker, R.H.; Steinach, M. Negative Energy Balance Does Not Alter Fat-Free Mass During theYukon Arctic Ultra—The Longest and the Coldest Ultramarathon. Front. Physiol. 2018, 9, 1761. [Google Scholar] [CrossRef] [Green Version]
- Szponar, L.; Wolnicka, K.; Rychlik, K.E. Album Fotografii Produktów i Potraw (in Polish); Instytut Żywności i Żywienia: Warsaw, Poland, 2000. [Google Scholar]
- Ndahimana, D.; Kim, E.K. Measurement Methods for Physical Activity and Energy Expenditure: A Review. Clin. Nutr. Res. 2017, 6, 68–80. [Google Scholar] [CrossRef] [Green Version]
- Perseghin, G.; Burska, A.; Lattuada, G.; Alberti, G.; Costantino, F.; Ragogna, F.; Oggionni, S.; Scollo, A.; Terruzzi, I.; Luzi, L. Increased serum resistin in elite endurance athletes insulin sensitivity. Diabetologia 2006, 49, 1893–1900. [Google Scholar] [CrossRef] [Green Version]
- Sansoni, V.; Vernillo, G.; Perego, S.; Barbuti, A.; Merati, G.; Schena, F.; La Torre, A.; Banfi, G.; Lombardi, G. Bone turnover response is linked to both acute and established metabolic changes in ultra-marathon runners. Endocrine 2017, 56, 196–204. [Google Scholar] [CrossRef]
- Shyu, K.G.; Chua, S.K.; Wang, B.W.; Kuan, P. Mechanism of inhibitory effect of atorvastatinon resistin expression induced by tumor necrosis factor-alpha in macrophages. J. Biomed. Sci. 2009, 16, 50. [Google Scholar] [CrossRef] [Green Version]
- Wiliams, D.L.; Ozment-Skelton, T.; Li, C. Modulation of the phosphoinositide 3-kinase signalling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury. Shock 2006, 25, 432–439. [Google Scholar] [CrossRef]
- Wolfe, B.; Jimerson, D.C.; Orlova, C.; Mantzoros, C.S. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin. Endocrinol. (Oxf.) 2004, 61, 332–338. [Google Scholar] [CrossRef] [PubMed]
- Dostalova, I.; Kunesova, M.; Duskova, J.; Papezova, H.; Nedvidkova, J. Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition 2006, 22, 977–983. [Google Scholar] [CrossRef] [PubMed]
- Edwards, K.H.; Elliott, B.T.; Kitic, C.M. Carbohydrate intake and ketosis in self-sufficient multi-stage ultramarathon runners. J. Sports Sci. 2020, 38, 366–374. [Google Scholar] [CrossRef] [PubMed]
- Ishihara, K.; Uchiyama, N.; Kizaki, S.; Mori, E.; Nonaka, T.; Oneda, H. Application of Continuous Glucose Monitoring for Assessment of Individual Carbohydrate Requirement during Ultramarathon Race. Nutrients 2020, 12, 1121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wołyniec, W.; Ratkowski, W.; Kasprowicz, K.; Małgorzewicz, S.; Aleksandrowicz, E.; Zdrojewski, T.; Wierucki, Ł.; Puch-Walczak, A.; Żmijewski, P.; Renke, M. Factors influencing post-exercise proteinuria after marathon and ultramarathon races. Biol. Sport 2020, 37, 33–40. [Google Scholar] [CrossRef] [PubMed]
- Waśkiewicz, Z.; Kłapcińska, B.; Sadowska-Krępa, E.; Czuba, E.; Kempa, K.; Kimsa, E.; Gerasimuk, D. Acute metabolic responses to a 24-h ultra-marathon race in male amateur runners. Eur. J. Appl. Physiol. 2012, 112, 1679–1688. [Google Scholar] [CrossRef] [Green Version]
- Hansen, E.A.; Emanuelsen, A.; Gertsen, R.M.; Sørensen, S.S.R. Improved marathon performance by in-race nutritional strategy intervention. Int. J. Sport Nutr. Exerc. Metab. 2014, 24, 645–655. [Google Scholar] [CrossRef] [PubMed]
- Kasprowicz, K.; Ziemann, E.; Ratkowski, W.; Laskowski, R.; Kaczor, J.J.; Dadci, R.; Antosiewicz, J. Running a 100-km ultra-marathon induces an inflammatory response but does not raise the level of the plasma iron-regulatory protein hepcidin. J. Sports Med. Phys. Fit. 2013, 53, 533–537. [Google Scholar]
Parameter | Mean Value ± SD or Median Value and IQR |
---|---|
Age (years) | 42.5 ± 8.9 a |
Body weight (kg) | 78.2 ± 8.8 a |
Height (cm) | 178.0 ± 4.3 a |
Body fat (%) | 13.3 ± 3.2 a |
Body fat free mass (kg) | 67.6 ± 5.9 a |
BMI (kg/m2) | 24.6 ± 2.2 a |
Duration of training (years) | 5.0 (3.5–6.0) b |
Weekly running distance (km) | 70 (45–85) b |
Parameter | Median and IQR |
---|---|
Distance (km) | 90.8 (70.8–100.0) |
Ultra-marathon time (h) | 10.0 (8.3–11.5) |
Ultra-marathon running velocity (km/h) | 8.7 (8.5–9.7) |
Energy intake during the run (kcal) | 1500 (1130–2026) |
Liquid intake during the run (ml) | 1850 (1300–2500) |
Energy expenditure (kcal) | 7167 (6266–8443) |
Energy balance (%) | 22.65 (16.92–26.70) |
Parameter | Pre-Race | Post-Race | p |
---|---|---|---|
hs-CRP (mg/L) | 0.52 (0.43–1.11) | 3.23 (1.87–8.11) | 0.0006 |
Resistin (ng/mL) | 5.26 (4.42–5.98) | 9.51 (8.60–12.64) | 0.0006 |
Chemerin (ng/mL) | 91.61 (85.17–104.45) | 87.15 (78.24–102.53) | 0.394 |
Glucose (mg/dL) | 88.0 (82.60–102.70) | 81.20 (78.80–100.00) | 0.649 |
Lactic acid (mmol/L) | 1.81 (1.71–2.40) | 2.22 (1.36–4.57) | 0.099 |
Chemerin Pre-Run | Chemerin Post-Run | |||
---|---|---|---|---|
r | p | r | p | |
Resistin pre-run | 0.617 | <0.05 | 0.198 | NS |
Resistin post-run | 0.367 | NS | 0.620 | <0.05 |
hs-CRP pre-run | 0.578 | <0.05 | 0.061 | NS |
hs-CRP post-run | 0.077 | NS | −0.334 | NS |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Czajkowska, A.; Ambroszkiewicz, J.; Mróz, A.; Witek, K.; Nowicki, D.; Małek, Ł. The Effect of the Ultra-Marathon Run at a Distance of 100 Kilometers on the Concentration of Selected Adipokines in Adult Men. Int. J. Environ. Res. Public Health 2020, 17, 4289. https://doi.org/10.3390/ijerph17124289
Czajkowska A, Ambroszkiewicz J, Mróz A, Witek K, Nowicki D, Małek Ł. The Effect of the Ultra-Marathon Run at a Distance of 100 Kilometers on the Concentration of Selected Adipokines in Adult Men. International Journal of Environmental Research and Public Health. 2020; 17(12):4289. https://doi.org/10.3390/ijerph17124289
Chicago/Turabian StyleCzajkowska, Anna, Jadwiga Ambroszkiewicz, Anna Mróz, Katarzyna Witek, Dariusz Nowicki, and Łukasz Małek. 2020. "The Effect of the Ultra-Marathon Run at a Distance of 100 Kilometers on the Concentration of Selected Adipokines in Adult Men" International Journal of Environmental Research and Public Health 17, no. 12: 4289. https://doi.org/10.3390/ijerph17124289